Get the free weekly contract digest
The latest new contracts, like GondolaBio’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.
New new contracts, summarized for you
No login, no app to check — it comes to you
See who's moving and how much in your market
GondolaBio and n-Lorem Foundation Partner to Advance Novel ASO Therapies for Genetic Diseases
Contract Type
partnership
San DiegoBiotechnologyHealth CareTherapeuticsDescription
n-Lorem, a nonprofit foundation, and GondolaBio have entered into multiple collaborations to discover novel ASO medicines for patients who are not currently served by available treatment options. n-Lorem will leverage its robust, automated, high-capacity ASO discovery platform and significant expertise in ASO technology to discover, screen and select ASO medicines to two prespecified biological targets in genetic diseases with significant unmet need. GondolaBio will move forward in the development of these new medicines.